4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Calphostin C/AG-CN2-0430-C100/100 µg
商品详细Adipogen/Calphostin C/AG-CN2-0430-C100/100 µg
Adipogen/Calphostin C/AG-CN2-0430-C100/100 µg
Adipogen/Calphostin C/AG-CN2-0430-C100/100 µg
商品编号: AG-CN2-0430-C100
品牌: Adipogen Inc
市场价: ¥2200.00
美元价: 1320.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsUCN1028C;PKF115-584;Cal-C
ProductTypeChemical
Properties
FormulaC44H38O14
MW790.8
CAS121263-19-2
RTECSFF7380000
Source/HostChemicalsIsolatedfromCladosporiumcladosporioidessp.
PurityChemicals≥95%(HPLC)
AppearanceDarkredtobrownsolid.
SolubilitySolubleinethanol,methanol,DMSOordimethylformamide.Poorlysolubleinwater.
InChiKeySRJYZPCBWDVSGO-UHFFFAOYSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Protectfromlightwheninsolution.
Use/StABIlityStableforatleast1yearafterreceiptwhenstoredat-20°C.
Afterreconstitutionprotectfromlightat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • PotentandhighlyspecificcellpermeableproteinkinaseC(PKC)inhibitor[1].TheinhibitionofPKCislight-dependent.
  • PKA,PKG,DAGkinase,phospholipaseD1andD2,myosinlightchainkinaseandc-Srcinhibitor.
  • Anticancercompound.Inhibitscellproliferationandstronglyinducesapoptosisinvitro.
  • InducerofendoplasmicreticulumER-stress.
  • ShowntodirectlyandpotentlyblockL-typeCachannels.
  • CalphostinCspecificallyinhibitscontraction-stimulatedglucosetransportbutnotinsulin-stimulatedglucosetransportinskeletalmuscle.
  • Wnt/β-catenin/lef-1signalinginhibitor.β-catenin/TCFantagoNIST.InhibitsWnt-activatedgenesinadose-dependentfashion
ProductReferences
  1. Calphostins(UCN-1028),novelandspecificinhibitorsofproteinkinaseC.I.Fermentation,isolation,physico-chemicalpropertiesandBIOLOGicalactivities:E.Kobayashi,etal.;J.Antibiot.(Tokyo)42,1470(1989)
  2. Calphostins,novelandspecificinhibitorsofproteinkinaseC.II.Chemicalstructures:T.Iida,etal.;J.Antibiot.(Tokyo).42,1475(1989)
  3. Useandspecificityofstaurosporine,UCN-01,andcalphostinCasproteinkinaseinhibitors:T.Tamaoki,etal.;MethodsEnzymol.201,340(1991)
  4. InhibitionofproteinkinaseCbycalphostinCislight-dependent:R.F.Burns,etal.;BBRC176,288(1991)
  5. CalphostinC,aspecificproteinkinaseCinhibitor,activateshumanneutrophils:effectonphospholipaseA2andaggregation:S.Svetlov&S.Nigam;Biochim.Biophys.Acta1177,75(1993)
  6. InhibitionofdiacylglycerolkinasebytheantitumoragentcalphostinC.EvidenceforsimilaritybetweentheactivesiteofdiacylglycerolkinaseandtheregulatorysiteofproteinkinaseC:C.Redman,etal.;Biochem.Pharmacol.50,235(1995)
  7. CalphostinC,awidelyusedproteinkinaseCinhibitor,directlyandpotentlyblocksL-typeCachannels:H.C.Hartzell&A.Rinderknecht;Am.J.Physiol.270,C1293(1996)
  8. CalphostinCsynergisticallyinducesapoptosiswithVP-16inlymphomacellswhichexpressabundantphosphorylatedBcl-2protein:M.Murata,etal.;Cell.Mol.LifeSci.53,737(1997)
  9. CalphostinCinducesselectivedisassemblyoftheGolgicomplexbyaproteinkinaseC-independentmechanism:M.Alonso,etal.;Eur.J.CellBiol.76,93(1998)
  10. GrowthinhibitioninducedbyRo31-8220andcalphostinCinhumanglioblastomacelllinesisassociatedwithapoptosisandinhibitionofCDC2kinase:MBegemann,etal.;AnticancerRes.18,3139(1998)
  11. CalphostinCtriggerscalcium-dependentapoptosisinhumanacutelymphoblasticleukemiacells:D.M.Zhu,etal.;Clin.CancerRes.4,2967(1998)
  12. CalphostinCisaninhibitorofcontraction,butnotinsulin-stimulatedglucosetransport,inskeletalmuscle:J.Ihlemann,etal.;ActaPhysiol.Scand.167,69(1999)
  13. PharmacokineticfeaturesandmetabolismofcalphostinC,anaturallyoccurringperylenequinonewithantileukemicactivity:C.L.Chen,etal.;Pharm.Res.16,1003(1999)
  14. PotentdirectinhibitionofmammalianphospholipaseDisoenzymesbycalphostin-c:V.A.Sciorra,etal.;Biochemistry40,2640(2001)
  15. CalphostinCasarapidandstronginducerofapoptosisinhumancoronaryarterysmoothmusclecells:K.D.Krueger,etal.;Int.Immunopharmacol.13,1751(2003)
  16. Calphostin-CinductionofvascularsmoothmusclecellapoptosisproceedsthroughphospholipaseDandmicrotubuleinhibition:X.L.Zheng,etal.;J.Biol.Chem.279,7112(2004)
  17. Small-moleculeantagonistsoftheoncogenicTcf/beta-cateninproteincomplex:M.Lepourcelet,etal.;CancerCell.5,91(2004)
  18. Golgicomplexdisassemblycausedbylight-activatedcalphostinCinvolvesMAPKandPKA:J.A.Morgado-Diaz,etal.;TissueCell39,161(2007)
  19. KillingofcancercellsbythephotoactivatableproteinkinaseCinhibitor,calphostinC,involvesinductionofendoplasmicreticulumstress:A.Kaul&W.AMaltese;Neoplasia11,823(2009)
  20. SmallmoleculeinhibitorsofWnt/beta-catenin/lef-1signalinginducesapoptosisinchroniclymphocyticleukemiacellsinvitroandinvivo:R.K.Gandhirajan,etal.;Neoplasia12,326(2010)
  21. Investigationof3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-dionesassmallmoleculeantagonistsofβ-catenin/TCFtranscription:J.Zeller,etal.;Bioorg.Med.Chem.Lett. 23,5814(2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。